(IVLU) iShares Edge MSCI Intl - Ratings and Ratios
International, Developed, Value, Stocks, Equity
Dividends
| Dividend Yield | 3.31% |
| Yield on Cost 5y | 6.77% |
| Yield CAGR 5y | 26.85% |
| Payout Consistency | 92.8% |
| Payout Ratio | - |
| Risk via 10d forecast | |
|---|---|
| Volatility | 13.0% |
| Value at Risk 5%th | 21.9% |
| Relative Tail Risk | 2.75% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.88 |
| Alpha | 29.62 |
| CAGR/Max DD | 1.53 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.485 |
| Beta | 0.657 |
| Beta Downside | 0.669 |
| Drawdowns 3y | |
|---|---|
| Max DD | 15.48% |
| Mean DD | 2.26% |
| Median DD | 1.44% |
Description: IVLU iShares Edge MSCI Intl November 10, 2025
The iShares Edge MSCI Intl Value Factor ETF (IVLU) seeks to track a value-focused index by allocating at least 80 % of its assets to the index’s component securities-or securities that are economically equivalent-and may use up to 20 % for futures, options, swaps, cash, or non-index holdings to enhance exposure.
Overview
Ticker Symbol: IVLU | ETF Type: Equity | Country of Origin: USA | Category: Foreign Large-Cap Value
Key data points (as of the most recent filing):
• Expense ratio: 0.20 % (below the average for large-cap value ETFs, which hovers around 0.30 %).
• Top sector allocations: Financials (~25 %), Consumer Staples (~15 %), and Health Care (~12 %), reflecting the classic value tilt toward dividend-paying, cash-rich industries.
• 12-month total return (YTD): ≈ +6 %, outperforming the MSCI World ex-USA Index’s ~+4 % but lagging the broader MSCI World’s ~+7 % amid a rising-rate environment that pressures value stocks.
For a deeper dive into how IVLU’s factor exposure compares with other value-oriented ETFs, you might explore the ValueRay platform’s side-by-side analytics.
What is the price of IVLU shares?
Over the past week, the price has changed by +2.23%, over one month by +4.06%, over three months by +7.85% and over the past year by +41.30%.
Is IVLU a buy, sell or hold?
What are the forecasts/targets for the IVLU price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 49.6 | 28.8% |
IVLU Fundamental Data Overview December 09, 2025
Beta = 0.96
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 2.98b USD (2.98b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 2.98b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 2.98b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.44% (E(2.98b)/V(2.98b) * Re(8.44%) + (debt-free company))
Discount Rate = 8.44% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for IVLU ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle